Location
Areas of Expertise
About Me
Dr. Kathryn Pepple is an ophthalmologist specializing in uveitis and medical retinal diseases. She completed her MD and PhD at Baylor College of Medicine, followed by an ophthalmology residency and medical retina fellowship at Duke University, and then a uveitis fellowship at the University of Washington.
Dr. Pepple's clinical practice focuses on treating patients with uveitis, including iritis, pars planitis, retinitis, choroiditis, and scleritis, as well as medical retinal conditions such as age-related macular degeneration, diabetic retinopathy, and retinal vascular diseases. Her patient care philosophy centers on preventing vision loss and blindness through high-quality clinical care and the development of new treatments.
As a clinician-scientist, Dr. Pepple is actively involved in research aimed at understanding the mechanisms of ocular inflammation and developing novel therapies for uveitis. Her work integrates advanced imaging technologies to improve both clinical and pre-clinical studies.
Training

Uveitis
2014University of Washington
Fellowship
Medical Retina
2013Duke University
Fellowship
Ophthalmology
2012Duke University
ResidencyTransitional year Internship
2009Houston Methodist Hospital
Residency
MD
2008Baylor College of Medicine
Medical School
Ph.D. in Genetics
2006Baylor College of Medicine
Masters / PhD
BS, Microbiology
1997University of Oklahoma-Norman Campus
Undergraduate
Awards & Honors
Research to Prevent Blindness Career Development Award
2017Research to Prevent Blindness
Alcon Research Institute Young Investigator Award
2017Alcon Research Institute
Latham Vision Science Innovation Award
2015Latham
NIH NEI K08 grant recipient
2014National Institutes of Health, National Eye Institute
Federation of Clinical Immunology Societies Travel Award
2014Federation of Clinical Immunology Societies
American Uveitis Society Fellow Travel Grant
2014American Uveitis Society
Heed Ophthalmic Foundation Fellowship award
2013Heed Ophthalmic Foundation
Publications & Press
Microglia-independent rAAV-induced inflammation causes persistent ocular immune dysregulation rescued by S1P receptor modulation.
Molecular therapy : the journal of the American Society of Gene Therapy•2026Clearing the AIR: A PRPH2 mutation identified in the evaluation of presumed autoimmune retinopathy
American Journal of Ophthalmology Case Reports•2025Safety and efficacy of CRISPR-mediated genome ablation of VEGFA as a treatment for choroidal neovascularization in nonhuman primate eyes.
Molecular therapy : the journal of the American Society of Gene Therapy•2024Aqueous Macrophages Contribute to Conserved CCL2 and CXCL10 Gradients in Uveitis.
Ophthalmology science•2023Cataract Surgery in Patients With Uveitis Treated With Systemic Therapy in the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study: Risk Factors and Outcomes
American Journal of Ophthalmology•2023
Certifications & Licensure
- Licensed In
- WA
- License Numbers
- MD60336664

